Table 4.

Estimation of EFS of 303 Patients With HD According to Cumulative Effect of sCD30 Serum Level and Stage of Disease Assessed at Diagnosis

sCD30 (U/mL) Stages 5-Yr EFS (%) 95% CI
<100 I-II  88.7  82-93  
<100  III-IV  83.1 66.8-91.8  
≥100  I-II  72.5  52-85.4  
≥100 III-IV  50.5  35-64.1 
sCD30 (U/mL) Stages 5-Yr EFS (%) 95% CI
<100 I-II  88.7  82-93  
<100  III-IV  83.1 66.8-91.8  
≥100  I-II  72.5  52-85.4  
≥100 III-IV  50.5  35-64.1 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal